Suppr超能文献

单次口服挑战以验证儿童牛奶过敏的激发剂量。

Single-dose oral challenges to validate eliciting doses in children with cow's milk allergy.

机构信息

Section of Inflammation, Repair and Development, National Heart & Lung Institute, Imperial College London, London, UK.

Paediatrics and Child Health, University College Cork, Ireland.

出版信息

Pediatr Allergy Immunol. 2021 Jul;32(5):1056-1065. doi: 10.1111/pai.13482. Epub 2021 Mar 13.

Abstract

BACKGROUND

There is increasing interest in the use of eliciting doses (EDs) to inform allergen risk management. The ED can be estimated from the distribution of threshold doses for allergic subjects undergoing food challenges within a specified population. Estimated ED values for cow's milk (the dose expected to cause objective allergic symptoms in 5% of the milk-allergic population) range from 0.5 mg to 13.9 mg cow's milk protein. We undertook a single-dose challenge study to validate a predicted ED for cow's milk of 0.5 mg protein.

METHODS

Participants were recruited from 4 clinical centres. Predetermined criteria were used to identify patients reacting to 0.5 mg cow's milk protein (approximately 0.015 mL of fresh cow's milk). Children over 1 year underwent formal challenge to cow's milk to confirm clinical reactivity.

RESULTS

172 children (median age 6.0 (IQR 0.7-11) years, 57% male) were included in this analysis. Twelve (7.0%, 95% CI 3.7%-11.9%) children experienced objective symptoms that met the predetermined criteria. One participant had mild anaphylaxis that responded to a single dose of adrenaline, the remainder experienced only mild symptoms with no treatment required. We did not identify any baseline predictors of sensitization that were associated with objective reactivity to the single-dose challenge using 0.5 mg cow's milk protein.

CONCLUSIONS

These data support an estimated ED for cow's milk of 0.5 mg protein. Values for ED above 0.5 mg for cow's milk protein proposed for allergen risk management need to be reviewed.

摘要

背景

人们越来越关注使用激发剂量 (ED) 来为过敏原风险管理提供信息。ED 可以从特定人群中接受食物挑战的过敏受试者的阈值剂量分布中估计。对于牛奶(预计会导致 5%牛奶过敏人群出现客观过敏症状的剂量),估计的 ED 值范围在 0.5 毫克至 13.9 毫克牛奶蛋白之间。我们进行了一项单剂量挑战研究,以验证 0.5 毫克蛋白质的牛奶预测 ED。

方法

参与者从 4 个临床中心招募。使用预定标准来识别对 0.5 毫克牛奶蛋白(约 0.015 毫升新鲜牛奶)有反应的患者。1 岁以上的儿童接受正式的牛奶挑战以确认临床反应性。

结果

本分析纳入了 172 名儿童(中位数年龄为 6.0(IQR 0.7-11)岁,57%为男性)。12 名(7.0%,95%CI 3.7%-11.9%)儿童出现了符合预定标准的客观症状。1 名参与者出现轻度过敏反应,对肾上腺素单剂量有反应,其余参与者仅出现轻度症状,无需治疗。我们没有发现任何基线预测指标与使用 0.5 毫克牛奶蛋白的单剂量挑战的客观反应相关。

结论

这些数据支持牛奶蛋白 0.5 毫克的估计 ED。用于过敏原风险管理的牛奶蛋白 ED 值高于 0.5 毫克需要重新评估。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验